These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as a Breast Mass. Rahal A; Reddy PS; Alvares C Cureus; 2015 Dec; 7(12):e408. PubMed ID: 26824008 [TBL] [Abstract][Full Text] [Related]
3. Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report. Adabifirouzjaei F; Khazai B; Azami G; Shoja-E-Razavi G J Med Case Rep; 2021 Oct; 15(1):539. PubMed ID: 34702349 [TBL] [Abstract][Full Text] [Related]
4. Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation. Devins K; Schuster SJ; Caponetti GC; Bogusz AM Diagn Pathol; 2018 Nov; 13(1):92. PubMed ID: 30470245 [TBL] [Abstract][Full Text] [Related]
5. A Diagnostic Dilemma of Sinonasal T Cell Lymphoma: Report of A Unique Case and Literature Review. V S; Thamby SP; Al-Hatamleh MAI; Mohamud R; Abdullah B Gulf J Oncolog; 2019 Sep; 1(31):83-89. PubMed ID: 31591996 [TBL] [Abstract][Full Text] [Related]
6. A Rare Case of Extranodal Natural Killer/T-cell Lymphoma, Nasal Type Associated With Hemophagocytic Lymphohistiocytosis in a Patient With Recurrent Sinusitis. Christensen BR; Kou CJ; Lee LE Cureus; 2024 Mar; 16(3):e56237. PubMed ID: 38618451 [TBL] [Abstract][Full Text] [Related]
7. Multimodality imaging evaluation of primary testicular extranodal natural killer/T-cell lymphoma: two case reports. Huang W; Liu X; Li L; Zhang Y; Gao Y; Gao J; Kang L Front Med (Lausanne); 2023; 10():1183564. PubMed ID: 37324131 [TBL] [Abstract][Full Text] [Related]
8. Modified SMILE (mSMILE) is active in the treatment of pediatric Epstein-Barr virus-associated natural killer/T-cell lymphoma: a single center experience, case series. Li J; Wu Q; Wang Y; Yi-Hsuan H; Du L; Kang M; Rong L; Fang Y Transl Pediatr; 2024 Jul; 13(7):1152-1160. PubMed ID: 39144442 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated natural killer/T-cell lymphomas. Asano N; Kato S; Nakamura S Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637 [TBL] [Abstract][Full Text] [Related]
10. Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as Refractory Reategui Schwarz E; Oikonomou KG; Reynolds M; Kim J; Balmiki RL; Sterling SA J Investig Med High Impact Case Rep; 2017; 5(3):2324709617716471. PubMed ID: 28748192 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs. Tajima S; Takanashi Y; Koda K; Fukayama M Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854 [TBL] [Abstract][Full Text] [Related]
12. A Case of Acute Extensive Viral Sinusitis Secondary to Acute Epstein Barr Virus. Khine S; Edupuganti S; Upadhyay M; Liroff K Eur J Case Rep Intern Med; 2023; 10(10):004039. PubMed ID: 37789985 [TBL] [Abstract][Full Text] [Related]
13. Extranodal NK/T-cell lymphoma, nasal type, with extranasal presentation - a case report and a review of the literature. Akbar M; Clasen-Linde E; Specht L Acta Oncol; 2020 Dec; 59(12):1480-1487. PubMed ID: 32689856 [TBL] [Abstract][Full Text] [Related]
14. Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report. Al Shawabkeh MA; Al Sulaiti M; Al Sa'ey H; Ganesan S Am J Case Rep; 2016 Dec; 17():934-938. PubMed ID: 27932776 [TBL] [Abstract][Full Text] [Related]
16. NK/T-cell lymphoma with rash and peripheral neuropathy as the first manifestation: a case report and literature review. Tian Z; Tian J; Liao J Diagn Pathol; 2023 Jan; 18(1):2. PubMed ID: 36627681 [TBL] [Abstract][Full Text] [Related]
17. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma. Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275 [TBL] [Abstract][Full Text] [Related]
18. Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data. Kim TY; Kim TJ; Han EJ; Min GJ; Jeon Y; Cho SG Front Oncol; 2024; 14():1362367. PubMed ID: 39144825 [TBL] [Abstract][Full Text] [Related]
19. A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma. Jiang M; Zhang L; Xie L; Zhang H; Jiang Y; Liu WP; Zhang WY; Tian R; Deng YT; Zhao S; Zou LQ Oncotarget; 2017 Jul; 8(30):50155-50163. PubMed ID: 28404973 [TBL] [Abstract][Full Text] [Related]
20. Pembrolizumab in newly diagnosed EBV-negative extranodal natural killer/T-cell lymphoma: A case report. Asif S; Begemann M; Bennett J; Fatima R; Masood A; Raza S Mol Clin Oncol; 2019 Mar; 10(3):397-400. PubMed ID: 30847181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]